High failure rate associated with 180° selective laser trabeculoplasty

Journal of Glaucoma

Volumn 14, Issue 5, 2005, Pages 400-408

  Song, Julia ^a   Lee, Paul P ^a   Epstein, David L ^a   Stinnett, Sandra S ^a   Herndon Jr , Leon W ^a   Asrani, Sanjay G ^a   Allingham, R Rand ^a   Challa, Pratap ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glaucoma; Intraocular pressure; Selective laser trabeculoplasty; Survival

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; CARBONATE DEHYDRATASE INHIBITOR; FLUOROMETHOLONE; LATANOPROST; LOTEPREDNOL ETABONATE; MIOTIC AGENT; PREDNISOLONE ACETATE; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; TRAVOPROST;

ADULT; AGED; ARTICLE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; OPEN ANGLE GLAUCOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PSEUDOEXFOLIATION; RETROSPECTIVE STUDY; SELECTIVE LASER TRABECULOPLASTY; SURVIVAL; TRABECULOPLASTY; TREATMENT FAILURE;

AGED; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER SURGERY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRABECULAR MESHWORK; TRABECULECTOMY; TREATMENT FAILURE;

EID: 25644433454     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000176939.43681.c2     Document Type: Article

References (69)

1. Damji KF, Shah KC, Rock WJ, et al. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83:718-722.
2. Kajiya S, Hayakawa K, Sawaguchi S. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi-Acta Societatatis Ophthalmol Japon. 2000;104:160-164.
3. Kaulen P, Richter A, Wiemer C. Druckverlauf in den ersten 20 Monaten nach selektiver Lasertrabekuloplastik-Eine Anwendungsbeobachtung. Klin Monatsbl Augenheilkd. 1998;214:S12.
4. Gracner T. Intraocular pressure response to selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Ophthalmologica. 2001; 215:267-270.
5. Kim HJ, Moon CS. One-year follow-up of laser trabeculoplasty using Q-switched Nd: YAG laser of 532nm wavelength. Ophthalmic Surg Lasers. 2000;31:394-396.
6. Kano K, Kuwayama Y, Mizoue S, et al. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi-Acta Societatis Ophthalmol Japon. 1999;103:612-616.
7. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma. Klin Oczna. 2000; 102:129-133.
8. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd: YAG laser trabeculoplasty (Selective Laser Trabeculoplasty). Ophthalmology. 1998;105:2082-2090.
9. Lanzetta P, Menchini U, Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol. 1999;83:29-32.
10. Gracner T. Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol. 2002;12:287-292.
11. Gracner T, Pahor D, Gracner B. Efficacy of selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Klin Monatsbl Augenheilkd. 2003;220:848-852.
12. Cvenkel B. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica. 2004;18:20-25.
13. Chen E, Golchin S, Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma. 2004;13:62-65.
14. Gaasterland D, Kupfer C. Experimental glaucoma in the rhesus monkey. Invest Ophthalmol. 1974;13:455-457.
15. Worthen DM, Wickham MG. Laser trabeculotomy in monkeys. Invest Ophthalmol. 1973;12:707-711.
16. Krasnov MM. Q-switched laser iridectomy and q-switched laser goniopuncture. Adv Ophthalmol. 1977;34:192-196.
17. Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma. Am J Ophthalmol. 1973;75:674-678.
18. Hager H. Besondere mikrochirugische Eingriffe. II. Berste Erfahrungen mit dem Argon-Laser-Great 800. Klin Monatsbl Augenheilkd. 1973;162: 437-450.
19. Ticho U, Nesher R. Laser trabeculoplasty in glaucoma. Ten-year evaluation. Arch Ophthalmol. 1989;107:844-846.
20. Kwasniewska S, Fankhauser F, Larsen SE, et al. The efficacy of cw Nd: YAG laser trabeculoplasty. Ophthalmic Surg. 1993;24:304-308.
21. Schwartz AL, Anderson DR. Trabecular surgery. Arch Ophthalmol. 1972; 92:134-138.
22. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma. Arch Ophthalmol. 1979;97:319-322.
23. Thomas JV, Simmons RJ, Belcher CD. Argon laser trabeculoplasty in the presurgical glaucoma patient. Ophthalmol. 1982;89:187-197.
24. Wilensky JT, Jampol LM. Laser therapy for open angle glaucoma. Ophthalmol. 1981;88:213-217.
25. Witschel B, Dannheim F, Rassow B. Experimental studies on laser trabeculo-puncture. Adv Ophthalmol. 1977;34:197-200.
26. Schwartz AL, Perman KI, Whitten M. Argon laser trabeculoplasty in progressive low-tension glaucoma. Ann Ophthalmol. 1984;16:560-566.
27. Schwartz AL, Whitten ME, Bleiman B, et al. Argon laser trabecular surgery in uncontrolled phakic open angle glaucoma. Ophthalmol. 1981; 88:203-212.
28. Threlkeld AB, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma. 1996;5:311-316.
29. Traverso CE, Rolando M, Calabria G, et al. Eye parameters influencing the results of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmologica. 1987;194:174-180.
30. Horns DJ, Bellows AR, Hutchinson BT, et al. Argon laser trabeculoplasty for open angle glaucoma a retrospective study of 380 eyes. Trans Ophthalmol Soc U K. 1983;103:288-295.
31. Wise JB. Long-term control of adult open angle glaucoma by argon laser treatment. Ophthalmology. 1981;88:197-202.
32. Adachi M, Shirato S, Kaburagi T, et al. Ten-year results of argon laser Trabeculoplasty. Nippon Ganka Gakkai Zasshi-Acta Societatis Ophthalmologicae Japonicae. 1994;98:374-378.
33. Schwartz A, Wilson MC, Schwartz LW. Efficacy of argon laser trabeculoplasty in aphakic and pseudophakic eyes. Ophthalmic Surg Lasers. 1997;28:215-218.
34. Rouhiainen H, Leino M, Terasvirta M. The effect of some treatment variables on long-term results of argon laser trabeculoplaty. Ophthalmologica. 1995;209:21-24.
35. Traverso CE, Spaeth GL, Starita RJ, et al. Factors affecting the results of argon laser trabeculoplasty in open-angle glaucoma. Ophthalmic Surg. 1986;17:554-559.
36. Elsas T. Primary laser trabeculoplasty a comparison of 50 spots in 180deg; and 100 spots in 360° of the trabecular meshwork. Acta Ophthalmol (Copenh). 1987;65:323-325.
37. Grinich NP, Van Buskirk M, Samples JR. Three-year efficacy in laser trabeculoplasty. Ophthalmol. 1987;94:858-861.
38. Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmol. 1993;100: 1324-1329.
39. Glaucoma Laser Trial Research Group. The glaucoma laser trial, II: Results of argon laser trabeculoplasty versus topical medications. Ophthalmology. 1990;97:1403-1413.
40. Tuulonen A. Laser trabeculoplasty as primary therapy in chronic open angle glaucoma. Acta Ophthalmol (Copenh). 1984;62:150-155.
41. Tuulonen A, Koponen J, Alanko HI, et al. Laser trabeculoplasty versus medication treatment as primary therapy for glaucoma. Acta Ophthalmol (Copenh). 1989;67:275-280.
42. Krupin T, Kolker AE, Kass MA, et al. Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmology. 1984;91:361-365.
43. Del Priore LV, Robin AL, Pollack IP. Long-term follow-up of neodymium: YAG laser angle surgery for open-angle glaucoma. Ophthalmology. 1988; 95:277-281.
44. Wilensky JT, Jampol LM. Laser therapy for open angle glaucoma. Ophthalmology. 1981;88:213-217.
45. Weinreb RN, Ruderman R, Juster R, et al. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol. 1983;95:279-299.
46. Heijl A, Bengtsson B. The short-term effect of laser trabeculoplasty on the glaucomatous visual field. A prospective study using computerized perimetry. Acta Ophthalmol (Copenh). 1984;62:705-724.
47. Lustgarden J, Podos SM, Ritch R, et al. Laser trabeculoplasty. A prospective study of treatment variables. Arch Ophthalmol. 1984;102: 517-519.
48. Wilensky JT, Weinreb RN. Low-dose trabeculoplasty. Am J Ophthalmol. 1983;95:423-426.
49. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res. 1995; 60:359-372.
50. Witschel B, Dannheim F, Rassow B. Experimental studies on laser trabeculopuncture. Adv Ophthalmol. 1977;34:197-200.
51. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001;108:773-779.
52. Tabak S, de Waard PWT, Lemji HG, et al. Selective laser trabeculoplasty in glaucoma. IOVS. 1998;39:S472.
53. Pirnazar JR, Wax MB, Kolker AE, et al. The efficacy of 532 nm laser trabeculoplasty [ARVO abstract]. IOVS. 1998;39:5.
54. Marteinz-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004;18:498-502.
55. Cvenkel B, Hvala A, Drnovsek-Olup B, et al. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med. 2003;33:204-208.
56. Melamed S, Simon GJB, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. Arch Ophthalmol. 2003;121:957-960.
57. Ticho U, Nesher R. Laser trabeculoplasty in glaucoma. Ten-year evaluation. Arch Ophthalmol. 1989;107:844-846.
58. Grinich NP, Van Buskirk M, Samples JR. Three-year efficacy in laser trabeculoplasty. Ophthalmology. 1987;94:858-861.
59. Shingleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmol. 1993;100: 1324-1329.
60. Weinreb RN, Toris CB, Gabelt BT, et al. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47: S53-S64.
61. Alvarado JA. Selective laser trabeculoplasty: underlying mechanism. Ophthalmol Management. 2002;3-5.
62. Barany E, Lutjen-Drecoll E. Is increased outflow resistance in glaucoma simplex caused by regional differences in trabecular meshwork density? Some methodologic and morphologic considerations clarifying this question. Klin Monatsbl Augenheilkd. 1989;195:315-318.
63. Linden C, Alm A. Latanoprost twice daily is less effective than once daily: indication of receptor subsenstivity? Curr Eye Res. 1998;17:567-572.
64. Tuulonen A, Airaksinen PJ, Kuulasmaa K. Factors influencing the outcome of laser Trabeculoplasty. Am J Ophthalmol. 1985;99:388-391.
65. Lutjen-Drecoll E. Risiken der medikamentosen Therapie bei okularer hypertension. Leydehecker W, Krieglstein GK. Okulare Hypertension. Heidelberg: Kaden Verlag; 1984: 27.
66. Kim YY, Glover BK, Shin DH, et al. Effect of topical anti-inflammatory treatment on the long-term outcome of laser trabeculoplasty. Fluorometholone-Laser Trabeculoplasty Study Group. Am J Ophthalmol. 1998; 126:721-723.
67. Pappas HR, Berry DP, Partamian L, et al. Topical indomethacin therapy before argon laser trabeculoplasty. Am J Ophthalmol. 1985;99:571-575.
68. Lai JS, Chua JK, Tham CC, et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol. 2004;32: 368-372.
69. Nagar N. Presented at American Academy of Ophthalmology Meeting. Anaheim, CA: November 2003.